Associate Professor Jordan Paradise researches and publishes on the legal, ethical, and social implications of emerging science and technologies such as genetics and nanotechnology. She joined the Seton Hall University School of Law as an Associate Professor in 2009. She teaches Food & Drug Law and an Advanced Writing seminar in the Fall.

Professor Paradise is actively involved in collaborative, interdisciplinary projects that examine the intersection of law, science and technology. She is currently a Principal Investigator on a 4-year National Science Foundation Grant No. 0608791, “Evaluating Oversight Models for Active Nanostructures and Nanosystems: Learning from Past Technologies in a Societal Context.” This multi-institution grant brings together experts in law, bioethics, public policy, medicine, engineering, and social science to integrate a range of analytic methods and perspectives in order to develop appropriate oversight frameworks for emerging products and applications of nanobiotechnology. She is an editor and author on an upcoming issue of the Journal of Law, Medicine and Ethics devoted to this topic. She has also served as an Investigator on several other private and federal grants addressing topics of law and science, including grants from the Greenwall Foundation and the National Institutes of Health. Her publications have appeared in both peer-reviewed and legal publications, including Science; Nature Reviews Genetics; Risk Analysis; Journal of Law, Medicine & Ethics; Food & Drug Law Journal; Yale Journal of Health Policy, Law & Ethics; Minnesota Journal of Law, Science & Technology; Temple Journal of Science, Technology & Environmental Law; and the International Journal of Intellectual Property Management.

Professor Paradise previously served as the Associate Director of Research & Education for the Joint Degree Program in Law, Health & the Life Sciences and the Consortium on Law and Values in Health, Environment & the Life Sciences at the University of Minnesota Law School from 2005-2009. She was also an Adjunct Associate Professor of Law, a Research Associate in the Center for Bioethics, and the Faculty Editor-in-Chief of the Minnesota Journal of Law, Science & Technology during her time at the University of Minnesota. From 2003-2005, Professor Paradise served as a Research Fellow at the Institute for Science, Law and Technology housed at Chicago-Kent College of Law and the Illinois Institute of Technology in Chicago, Illinois. She received her B.S. from the University of Michigan in Ann Arbor and her J.D. from Chicago-Kent College of Law with a certificate in Intellectual Property Law. She is a member of the Illinois Bar.

PUBLICATIONS

The Challenge of Developing Oversight Approaches to Nanobiotechnology, _ J. L. Med. & Ethics _ (forthcoming 2009) (with Susan M. Wolf, Jennifer Kuzma, Gurumurthy Ramachandran, and Efrosini KOkkoli).

Evaluating Oversight of Human Drugs and Medical Devices: A Case Study of the FDA and Implications for Nanobiotechnology, _ J. L. Med. & Ethics _ (forthcoming 2009) (with Alison W. Tisdale, Ralph Hall, & Efrosini Kokkoll).

Comparative Report--Developing U.S. Oversight Strategies for Nanobiotechnology: Learning from Past Oversight Experiences, _ J. L. Med. & Ethics _ (forthcoming 2009) (with Susan M. Wolf, Jennifer Kuzma, Aliya Kuzhabekova, ALison W. Tisdale, Gurumurthy Ramachandran, and Efrosini Kokkoli).

Patient Advocacy Group Collaboration in Genetic Research and The Scope of Joint Inventorship under U.S. Patent Law, 3(2) Int'l J. OF INTELLECTUAL PROPERTY MANAGEMENT 97-109 (2009).

An Integrated Approach to Oversight Assessment for Emerging Technologies, 28(5) RISK ANALYSIS 1197-1220 (2008) (Advance online publication July 9, 2008: DOI: 10.1111/j.1539-6924.2008.01086.x) (with Jennifer Kuzma, Gurumurthy Ramachandran, Jee-Ae Kim, Adam Kokotovich, & Susam M. Wolf).

Genetic Sequence Patents: Historical Justification and Current Impacts, in MAX PLANCK INSTITUTE OCCASIONAL PAPER SERIES: LIVING PROPERTIES/MAKING KNOWLEDGE AND CONTROLLING OWNERSHIP IN THE HISTORY OF BIOLOGY (May 2008) (with Lori Andrews).

The Law of Incidental Findings in Human Subjects Research, 36(2) J.L.Med. & Ethics 361-383 (2008) (with Susan M. Wolf & Charlisse Caga-anan).

Managing Incidental Findings in Human Subjects Research: Analysis and Recommendations, 36(2) J. L. Med. & Ethics 219-248 (2008) (with Frances P. Lawrenz, CHales A. Nelson, Jeffrey P. Kahn, Mildred K. Cho, Ellen Wright Clayton, Joel G. Fletcher, Michael K. Georgieff, Dale Hammerschmidt, Kathy Hudson, Judy Illes, Vivek Kapur, Moira A. Keane, Barbara A. Koenig, Bonnie S. LeRoy, Elizabeth G. McFarland, Lisa S. Parker, Sharon F. Terry, Brian Van Ness, & Benjamin S. Wilfond).

Exploring Emerging Nanobiotechnology Drugs and Medical Devices, 63(2) Food and Drug L.J. 407-420 (2008) (with Gail M. Diliberto, Alison W. Tisdale, & Efrosini Kokkoli).

Developing Oversight Frameworks for Nanobiotechnology, 9(1) Minnesota J. L. Science & Tech. 187-203 (Winter 2008) (with Susan M. Wolf, Gurumurthy Ramachandran, Efrosini Kokkoli, Ralph Hall, & Jennifer Kuzma).

Tales from the Crypt: Scientific, Ethical, and Legal Considerations for Biohistorical Analysis of Deceased Historical Figures, 26 Temple J. Of Science, Tech. & Environ. Law 223-299 (Fall 2007) (with Lori Andrews).

Banning Gene Patents Can Bring Benefits, 1(39) BIOWORLD TODAY , (September 20, 2007) (with Lori Andrews).

National Conference on Research Cloning, PERSPECTIVES: THE MAGAZINE FOR THE UNIVERSITY OF MINNESOTA LAW SCHOOL (Spring 2007).

When Patents Threaten Science, 314 Science 1395-96 (2006) (with Lori Andrews, Timothy Holbrook, & Danielle Bochneak).

Decoding the Research Exemption, 7(2) Nature Reviews Genetics 148-154 (2006) (with Christphopher Janson).

Lessons from the European Union: The Need for a Post-Grant Mechanism for Third Party Challenge to U.S. Patents, 7(1) Minnesota J.L. Science & Tech. 315-326 (2005).

Problems in Patenting Human Genes, 308 Science 1869 (2005) (with Lori Andrews & Timothy Holbrook).

Call for Biohistory Guidelines, 2 PLOS MEDICINE e192 (2005).

Patents on Human Genes: An Analysis of Scope and Claims, 307 Science 1566-1567 (2005) (with Lori Andrews & Timothy Holbrook).

Gene Patents: The Need for Bioethics Scrutiny and Legal Change, 5 Yale J. Health Pol'y, L. & Ethics 403-412 (2005) (with Lori Andrews).

European Opposition to Exclusive Control Over Predictive Breast Cancer Testing and the Inherent Implications for United States Patent Law and Public Policy: A Case Study of the Myriad Genetics’ BRCA Patent Controversy, 59(1) Food and Drug L.J. 133-154 (2004).

Constructing Ethical Guidelines for Biohistory, 304 Science 214-215 (2004) (with Lori Andrews, Nancy Buenger, Jennifer Bridge, Laurie Rosenow, David Stoney, R.E. Gaensslen, Theodore Karamanski, Russell Lewis, Amy Inlander, & David Gonen).

Gene Patents and Bioethics in TOWARDS A DECLARATION ON UNIVERSAL NORMS ON BIOETHICS EXTRAORDINARY SESSION OF THE INTERNATIONAL BIOETHICS COMMITTEE, Paris, April 27-29, 2004 (with Lori Andrews).